project id: TCGA-LGG; case submitter id: TCGA-P5-A5ET; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; a260 a280 ratio: 1.84; normal tumor genotype snp match: Yes; ribosomal rna 28s 16s ratio: 1.6; rna integrity number: 7.8; age at index: 27; days to birth: -10027; ethnicity: not hispanic or latino; gender: male; race: white; vital status: Alive; year of birth: 1985; age at diagnosis: 10027; classification of tumor: not reported; days to diagnosis: 0; days to last follow up: 0.0; icd 10 code: C71.0; last known disease status: not reported; morphology: 9450/3; primary diagnosis: Oligodendroglioma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Cerebrum; synchronous malignancy: No; tissue or organ of origin: Cerebrum; tumor grade: Not Reported; year of diagnosis: 2012; treatment or therapy: not reported; alcohol history: Not Reported; is ffpe: false; composition: Not Reported; days to collection: 98; initial weight: 400.0; sample id: d6725a25-19cd-49c3-96ba-a3fe3299ad0d; sample submitter id: TCGA-P5-A5ET-01A; portion id: 2cd9cdf1-7615-4641-b65f-18cdf098ab0b; portion submitter id: TCGA-P5-A5ET-01A-11; slide id: 3733c4a4-9d3e-4a02-be96-cf0c7e4664b1; slide submitter id: TCGA-P5-A5ET-01A-01-TSA; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 5.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 20.0; percent stromal cells: 50.0; percent tumor cells: 30.0; percent tumor nuclei: 80.0; section location: TOP;